Recurrent Dupuytren Disease


Dupuytren disease poses two challenges to the treating surgeon: prevention of its recurrence through the primary procedure used for treating it, and treatment of its recurrence. As compared with average recurrence-free intervals after fasciectomy for Dupuytren disease, such intervals are shorter after minimally invasive treatment and longer after dermofasciectomy. In addition to surgical technique, local anatomy and diathetic factors influence the risk of recurrence of Dupuytren disease after its treatment. Recontracture may be due to the biology of Dupuytren disease, to pathologic changes resulting from its prior treatment, to tissue changes resulting from chronic joint contracture, or to a combination of these factors. A logical approach to treating recurrent Dupuytren disease requires consideration of the technique used for its prior treatment, the timeline to recontracture, the degree of deformity incurred by the disease, and patient selection.

This content is only available to members of the AAOS.

Please log in using the link at the top right corner of this page to access your exclusive AAOS member content.

Not a member? Become a member!